Cephalon, as a pharmaceutical company, has developed a variety of products that have received approval from the United States Food and Drug Administration, commonly known as the FDA. The approval process for pharmaceuticals is rigorous, requiring extensive research and clinical trials to demonstrate safety and efficacy before any product can be marketed to the public. Cephalon's focus has primarily been on developing medications for central nervous system disorders, pain management, and oncology, among other therapeutic areas. Each product that has been released typically comes with specific indications for use, along with thorough documentation of its clinical trial results. For a comprehensive list of Cephalon's FDA-approved products and their specific indications, it is beneficial to look at the current information available on their official webpage, as it provides the most accurate and up-to-date details regarding product approvals and related inquiries.